Hypofractionated Radiotherapy for Thymic Epithelial Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hypofractionated Radiotherapy for Thymic Epithelial Tumors — Stella

Recruiting

Back to Thymoma and Thymic Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Xiangya Hospital, Central South University, Changsha, Hunan

Key details

Sponsor

Rongrong Zhou

Enrollment target

~100 participants

Started

October 2024

Primary completion

November 2027

Age range

18 Years – 75 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov